跳至主要内容
临床试验/NCT02574975
NCT02574975Unknown4 期

Comparison of Different Methodologies Assessing Airway Responsiveness and Investigation of Treatment Efficacy of Budesonide /Formoterol in Asthmatics

Zhujiang Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
80
试验地点
1
主要终点
positive rate of BPT in each group

研究概览

简要总结

Bronchial asthma is a common chronic respiratory disease. Patients usually manifest variable symptoms (such as short of breath, chest tightness, cough, etc.) and variable airflow limitation and often associated with airway hyper-responsiveness and airway inflammation. About 1-18% of the global population suffered from the disease, causing huge economic burden for patients and countries. Airway reactivity measurement is an important way of diagnosis of asthma. Methacholine (Mch) bronchial provocation test(BPT) is the "gold standard" for the determination of airway reactivity, and other measuring methods(like adenosine monophosphate(AMP)-BPT, leukotriene D4(LTD4)-BPT, Astograph-BPT, etc.) were also brought into hot research fields. The investigators' purposes were to compare different kinds of methodologies(Mch,AMP,LTD4-BPT, Astograph-BPT) assessing airway responsiveness and to investigate treatment efficacy of budesonide /formoterol in asthmatics.

详细描述

This study composed of two parts, that were the diagnosing part and the treatment part.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
14 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically diagnosed Asthmatic patients aged from14 to 65 years;
  • Had a had a normal chest radiographic result;
  • Had a baseline spirometry with the forced expiratory volume in one second (FEV1) of not less than 60% predicted;
  • Without acute upper respiratory tract infection for the past 2 weeks

排除标准

  • Had a poor cooperation to the test or limited understandings;
  • Had a past confirmed history of respiratory disease other than bronchial asthma (COPD, bronchiectasis, pulmonary thromboembolism, etc.) or other severe systemic disease(myocardial infarction, malignant tumor, etc.);
  • Pregnancy or breast-feeding women;
  • Taken related drugs before measurements(Leukotriene receptor antagonists (LTRA) for 5 days,oral glucocorticosteroid or anti-histamine for 3 days,oral xanthenes or long-acting bronchodilators for 2 days,inhaled corticosteroid or long-acting bronchodilator for a day , short-acting bronchodilator for 4 hours )

研究组 & 干预措施

Methacholine diagnosing group

Active Comparator

Methacholine bronchial provocation test was performed by using Jaeger spirometry with Aerosol Provocation System

干预措施: methacholine (Drug)

Adenosine monophosphate diagnosing group

Experimental

Adenosine monophosphate bronchial provocation test was performed by using Jaeger spirometry with Aerosol Provocation System

干预措施: adenosine monophosphate (Drug)

Leukotriene D4 diagnosing group

Experimental

Leukotriene D4 bronchial provocation test was performed by using Jaeger spirometry with Aerosol Provocation System

干预措施: leukotriene D4 (Drug)

Astograh diagnosing group

Experimental

Methacholine bronchial provocation test was performed by using Astograph Jupiter-21 airway reaction testing apparatus

干预措施: Astograph Jupiter-21 airway reaction testing apparatus (Device)

budesonide /formoterol treatment group

Experimental

budesonide 160μg and formoterol 4.5ug,1 inhalation ,twice daily ,for three month

干预措施: budesonide /formoterol (Drug)

结局指标

主要结局

positive rate of BPT in each group

时间窗: 3months

comparing positive rates of BPT in experimental groups and control group

次要结局

  • Fractional exhaled nitric oxide(FeNO)(3months)
  • Forced expiratory volume at one second(FEV1)(3months)
  • Provocative dosage causing a 20% fall in FEV1(PD20-FEV1)(3months)

研究者

发起方
Zhujiang Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验